Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Glycoconj J ; 29(5-6): 347-56, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22847114

RESUMO

Beta1, 4-Galactosyltransferase-I (ß1, 4-GalT-I), which transfers galactose from UDP-Gal to N-acetylglucosamine and N-acetylglucosamine-terminated oligosaccharides of N- and O-linked glycans in a ß(1-4) linkage, plays a critical role in cell adhesion, sperm-egg recognition, neurite growth, and tumor cell migration and invasion. Our previously experiments also show that ß1, 4-GalT-I was up-regulated by estrogens and some important cytokines of embryo implantation especially Interleukin-1 (IL-1), TGF-α and Leukemia Inhibitory Factor (LIF) in endometrial cells. In the receptive phase human uterus, osteopontin (OPN) is the most highly up-regulated extracellular matrix/adhesion molecule/cytokine. In this study, we demonstrated the correlated expression of OPN and ß1, 4-GalT-I in endometrium during early pregnancy, and recombinant human OPN (rhOPN) protein induced the ß1, 4-GalT-I up-regulation in RL95-2 cells. Inhibition of MEK/ERK, PI3K/AKT and NF-κB suppressed rhOPN-induced ß1, 4-GalT-I expression. In addition, rhOPN promoted the adhesion of blastocysts cells in vitro in ß1, 4-GalT-I-dependent manner. Moreover, the adhesion is greatly inhibited when ß1, 4-GalT-I was blocked with the specific antibody. Taken together, our data suggest that ß1, 4-GalT-I provides a mechanism to bridge embryo to endometrium during implantation.


Assuntos
Implantação do Embrião/efeitos dos fármacos , Endométrio/efeitos dos fármacos , Galactosiltransferases/genética , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Osteopontina/genética , Proteínas Recombinantes/genética , Animais , Anticorpos/farmacologia , Adesão Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Endométrio/citologia , Endométrio/metabolismo , Feminino , Galactosiltransferases/antagonistas & inibidores , Galactosiltransferases/metabolismo , Humanos , Camundongos , Quinases de Proteína Quinase Ativadas por Mitógeno/antagonistas & inibidores , Quinases de Proteína Quinase Ativadas por Mitógeno/genética , NF-kappa B/antagonistas & inibidores , NF-kappa B/genética , Osteopontina/metabolismo , Osteopontina/farmacologia , Fosfatidilinositol 3-Quinases/genética , Inibidores de Fosfoinositídeo-3 Quinase , Gravidez , Inibidores de Proteínas Quinases/farmacologia , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia , Transdução de Sinais/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...